India’s market regulator, Sebi, upheld its ban on Farm Tech Silo LLP, also known as Growpital, and its related entities from securities markets pending an investigation into unauthorized investment schemes. Although the directors’ bank accounts were unfrozen, the ban on market activities remains in place to prevent potential fund misuse. Sebi cited ongoing uncertainties regarding revenue clarity, exaggerated land cultivation claims, and financial submission deficiencies as reasons for the continued restraint. The regulator’s probe revealed over Rs 184 crore mobilized in Growpital’s escrow account, indicating a significant risk to investors.
Sebi Maintains Securities Market Ban on Growpital Amid Probe
![](https://affairsace-media.s3.ap-south-1.amazonaws.com/2024/04/30155412/1710091863-68411-ezgif.com-avif-to-jpg-converter.jpg)